Home > Insider Trading > Filing (0001437749-23-028657)

Filing Details

Accession Number:: 0001437749-23-028657
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-10-20 12:04:51
Reporting Period:: 2023-07-01

Accepted Time:: 2023-10-20 12:04:51
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1402945	Progressive Care Inc.	RXMD	Retail-Drug Stores And Proprietary Stores (5912)	320186005

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1509529	M. Charles Fernandez	C/O Nextplat Corp 3250 Mary St., Suite 410 Coconut Grove FL 33133	Chairman & Ceo	Yes	Yes	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2023-07-01	228,240	$2.20	1,557,356	No	4	X	Indirect	By eAperion Partners LLC
Common Stock	Disposition	2023-07-01	112,838	$4.45	1,444,518	No	4	S	Indirect	By eAperion Partners LLC
Common Stock	Acquisiton	2023-07-01	190,000	$2.20	1,634,518	No	4	X	Indirect	By eAperion Partners LLC
Common Stock	Disposition	2023-07-01	93,932	$4.45	1,540,586	No	4	S	Indirect	By eAperion Partners LLC
Common Stock	Acquisiton	2023-07-01	455,000	$2.20	1,995,586	No	4	X	Indirect	By NextPlat Corp
Common Stock	Disposition	2023-07-01	224,944	$4.45	1,770,642	No	4	S	Indirect	By NextPlat Corp
Common Stock	Acquisiton	2023-07-01	340,599	$2.20	2,111,241	No	4	X	Indirect	By NextPlat Corp
Common Stock	Disposition	2023-07-01	168,386	$4.45	1,942,855	No	4	S	Indirect	By NextPlat Corp
Common Stock	Acquisiton	2023-07-01	230,000	$2.20	2,172,855	No	4	X	Indirect	By NextPlat Corp

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	X	Indirect	By eAperion Partners LLC
No	4	S	Indirect	By eAperion Partners LLC
No	4	X	Indirect	By eAperion Partners LLC
No	4	S	Indirect	By eAperion Partners LLC
No	4	X	Indirect	By NextPlat Corp
No	4	S	Indirect	By NextPlat Corp
No	4	X	Indirect	By NextPlat Corp
No	4	S	Indirect	By NextPlat Corp
No	4	X	Indirect	By NextPlat Corp

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrant	Acquisiton	2023-07-01	228,240	$0.00	228,240	$2.20
Common Stock	Common Stock Warrant	Acquisiton	2023-07-01	190,000	$0.00	190,000	$2.20
Common Stock	Common Stock Warrant	Acquisiton	2023-07-01	455,000	$0.00	455,000	$2.20
Common Stock	Common Stock Warrant	Acquisiton	2023-07-01	340,599	$0.00	340,599	$2.20
Common Stock	Common Stock Warrant	Acquisiton	2023-07-01	230,000	$0.00	230,000	$2.20

Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
2023-05-09	2028-05-09	No	4	X	Indirect
2023-05-09	2026-05-09	No	4	X	Indirect
2023-05-09	2026-05-09	No	4	X	Indirect
2023-05-09	2026-05-09	No	4	X	Indirect
2023-05-09	2028-05-09	No	4	X	Indirect

Footnotes

On July 1, 2023, eAperion Partners, LLC exercised a Conversion Warrant to purchase 228,240 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 112,838 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 115,402 shares.
On July 1, 2023, eAperion Partners, LLC exercised an Inducement Warrant to purchase 190,000 shares of RXMD common stock for $2.20 a share. eAperion Partners, LLC paid the exercise price on a cashless basis, resulting in RXMD's withholding of 93,932 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 96,068 shares.
On July 1, 2023, NextPlat Corp exercised a Warrant to purchase 455,000 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 224,944 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 230,056 shares.
On July 1, 2023, NextPlat Corp exercised a Conversion Warrant to purchase 340,599 shares of RXMD common stock for $2.20 a share. NextPlat Corp paid the exercise price on a cashless basis, resulting in RXMD's withholding of 168,386 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 172,213 shares.
On July 1, 2023, NextPlat Corp, exercised a Conversion Warrant to purchase 230,000 shares of RXMD common stock for $2.20 per share. NextPlat Corp paid the exercise price on a cash basis.
The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
The Reporting Person is the sole member and managing member of eAperion Partners LLC.
Includes 18,261 shares of common stock directly held by the Reporting Person; 1,071,251 shares of common stock held indirectly by NextPlat Corp., of which the Reporting Person is the Chief Executive Officer; and 239,604 shares of common stock held indirectly by eAperion Partners LLC, of which the Reporting person is the sole member and managing member.